{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:46:42Z","timestamp":1792882002559,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.bioorg.2018.08.012","type":"journal-article","created":{"date-parts":[[2018,8,11]],"date-time":"2018-08-11T02:45:53Z","timestamp":1533955553000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)"],"prefix":"10.1016","volume":"81","author":[{"given":"Srikanth","family":"Gatadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Gour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjulika","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravikumar","family":"Akunuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.V.","family":"Madhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.08.012_h0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hs.2014.0088","article-title":"Antimicrobial resistance is a global health emergency","volume":"13","author":"Toner","year":"2015","journal-title":"Health Secur."},{"key":"10.1016\/j.bioorg.2018.08.012_h0010","doi-asserted-by":"crossref","first-page":"16187","DOI":"10.1038\/nmicrobiol.2016.187","article-title":"Combating antimicrobial resistance globally","volume":"1","author":"Sugden","year":"2016","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bioorg.2018.08.012_h0015","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1476-0711-12-22","article-title":"New antibiotics for bad bugs: where are we?","volume":"12","author":"Bassetti","year":"2013","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"10.1016\/j.bioorg.2018.08.012_h0020","first-page":"127","article-title":"Capsule commentaries: drug reaction considerations with oral minocycline, skin","volume":"2","author":"Del Rosso","year":"2018","journal-title":"J. Cutan. Med."},{"key":"10.1016\/j.bioorg.2018.08.012_b0015","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1073\/pnas.122108599","article-title":"The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)","volume":"99","author":"Enright","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bioorg.2018.08.012_h0030","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus","volume":"340","author":"Smith","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2018.08.012_h0035","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bioorg.2018.08.012_h0040","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1574-6968.1992.tb05089.x","article-title":"Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus","volume":"93","author":"Noble","year":"1992","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bioorg.2018.08.012_h0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2018.08.012_h0050","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijmm.2017.12.002","article-title":"Differential daptomycin resistance development in Staphyloccocus aureus strains with active and mutated gra regulatory systems","volume":"308","author":"M\u00fcller","year":"2017","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.bioorg.2018.08.012_h0055","doi-asserted-by":"crossref","first-page":"5285","DOI":"10.1128\/JCM.43.10.5285-5287.2005","article-title":"Development of daptomycin resistance in vivo in methicillin-resistant Staphylococcus aureus","volume":"43","author":"Hayden","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.bioorg.2018.08.012_b0030","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2018.08.012_b0035","doi-asserted-by":"crossref","first-page":"e02397","DOI":"10.1128\/AAC.02397-17","article-title":"Antimicrobial activity of dalbavancin against Staphylococcus aureus with decreased susceptibility to glycopeptides, daptomycin, and\/or linezolid from U.S. medical centers","volume":"62","author":"Sader","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2018.08.012_b0040","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1574-6976.2003.tb00628.x","article-title":"Mechanism of action of oritavancin and related glycopeptide antibiotics","volume":"26","author":"Allen","year":"2003","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.bioorg.2018.08.012_h0075","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.idc.2009.06.007","article-title":"Newer beta-lactam antibiotics: doripenem, ceftobiprole, ceftaroline, and cefepime","volume":"23","author":"Bazan","year":"2009","journal-title":"Infect. Dis. Clin."},{"key":"10.1016\/j.bioorg.2018.08.012_h0080","doi-asserted-by":"crossref","first-page":"2960","DOI":"10.1128\/AAC.05004-14","article-title":"Ceftobiprole-and ceftaroline-resistant methicillin-resistant Staphylococcus aureus","volume":"59","author":"Chan","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2018.08.012_b0050","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/jhet.3099","article-title":"Synthesis and antibacterial activity of 2-substitued-(3-pyridyl)-quinazolinone derivatives","volume":"55","author":"Zhang","year":"2018","journal-title":"J. Heterocycl. Chem."},{"key":"10.1016\/j.bioorg.2018.08.012_h0090","first-page":"083","article-title":"Design, synthesis and preliminary pharmacological screening (antimicrobial, analgesic and anti-inflammatory activity) of some novel quinazoline derivatives","volume":"7","author":"Dash","year":"2017","journal-title":"J. Appl. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2018.08.012_h0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molstruc.2017.11.087","article-title":"Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine\u2013quinazolinone based hybrids","volume":"1156","author":"Dinari","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2018.08.012_b0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1871524917666170104142033","article-title":"Synthesis, molecular dockingand evaluation of 3-{4-[2-amino-4-(substitutedphenyl)-2H-[1,3]oxazin\/thiazin-6-yl}2-phenyl-3Hquinazolin-4-one derivatives for their anticonvulsant activity","volume":"18","author":"Jain","year":"2018","journal-title":"Cent. Nerv. Syst. Agents. Med Chem."},{"key":"10.1016\/j.bioorg.2018.08.012_b0065","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejmech.2016.05.066","article-title":"Synthesis, anti-inflammatory, analgesic, COX-1\/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4 (3H)-quinazolinones","volume":"121","author":"Alaa","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.012_h0110","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11030-017-9792-1","article-title":"Synthesis of novel (E)-2-(4-(1H\u20131, 2, 4-triazol-1-yl) styryl)-4-(alkyl\/arylmethyleneoxy) quinazoline derivatives as antimicrobial agents","volume":"22","author":"Yang","year":"2018","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2018.08.012_h0115","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.micpath.2018.02.018","article-title":"In vitro evaluation of new 2-phenoxy-benzo [g][1, 2, 4] triazolo [1,5-a] quinazoline derivatives as antimicrobial agents","volume":"117","author":"Abuelizz","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioorg.2018.08.012_h0120","first-page":"134","article-title":"Synthesis and evaluation of antifungal activities of (3H)-quinazolin-4-one derivatives against tree plant fungi","volume":"8","author":"Ighachane","year":"2017","journal-title":"J. Mater. Environ. Sci."},{"key":"10.1016\/j.bioorg.2018.08.012_b0075","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.bmcl.2017.05.064","article-title":"Synthesis and structure\u2013activity relationship study of novel quinazolinone based inhibitors of Mur A","volume":"27","author":"Hrast","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.08.012_h0130","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00044-017-2083-7","article-title":"New series of 4 (3H)-quinazolinone derivatives: syntheses and evaluation of antitumor and antiviral activities","volume":"27","author":"Abbas","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2018.08.012_h0135","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/acs.jmedchem.7b01474","article-title":"Quinazolinone based anticancer agents: synthesis, antiproliferative SAR, antitubulin activity, and tubulin co-crystal structure","volume":"61","author":"Dohle","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.012_b0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jsps.2013.03.004","article-title":"Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents","volume":"22","author":"Zayed","year":"2014","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2018.08.012_b0090","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00044-012-0037-7","article-title":"Synthesis, analgesic, anti-inflammatory, and in vitro antimicrobial activities of some novel quinazolin-4 (3H)-one derivatives","volume":"22","author":"Saravanan","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2018.08.012_b0095","doi-asserted-by":"crossref","first-page":"e1700513","DOI":"10.1002\/cbdv.201700513","article-title":"Synthesis, cytotoxic, and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety","volume":"15","author":"Zhan","year":"2018","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2018.08.012_b0100","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.bmcl.2016.04.012","article-title":"Synthesis, biological evaluation and structure\u2013activity relationship of 2-styrylquinazolones as anti-tubercular agents","volume":"26","author":"Jadhavar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.08.012_b0105","first-page":"804","volume":"65","author":"Desai","year":"1988","journal-title":"J. Indian. Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.08.012_b0110","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/acs.jmedchem.6b00372","article-title":"Structure-activity relationship for the 4 (3 H)-quinazolinone antibacterials","volume":"59","author":"Bouley","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.08.012_b0115","unstructured":"P.A. Wayne, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, Approved Standard, ninth ed., CLSI document M07-A9, Clinical and Laboratory Standards Institute, 2012."},{"key":"10.1016\/j.bioorg.2018.08.012_b0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jpha.2015.11.005","article-title":"Methods for in vitro evaluating antimicrobial activity: a review","volume":"6","author":"Balouiri","year":"2016","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bioorg.2018.08.012_b0125","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1038\/s41598-017-11575-5","article-title":"Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity","volume":"7","author":"Pandey","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2018.08.012_b0130","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2147\/IDR.S152335","article-title":"Interaction between rpsL and gyrA mutations affects the fitness and dual resistance of Mycobacterium tuberculosis clinical isolates against streptomycin and fluoroquinolones","volume":"11","author":"Sun","year":"2018","journal-title":"Infect. Drug. Resist."},{"key":"10.1016\/j.bioorg.2018.08.012_h0190","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s40011-016-0761-8","article-title":"Genoprotection and cytotoxicity of cassia surattensis seed extract on vero cell evaluated by comet and cytotoxicity assays","volume":"88","author":"Kumar","year":"2018","journal-title":"Proc. Nat. Acad. Sci., India Sect. B: Biol. Sci."},{"key":"10.1016\/j.bioorg.2018.08.012_h0195","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.sajb.2018.02.155","article-title":"Antimicrobial efficacy and safety of acetone crude leaf extracts of eight under-investigated plants from the Myrtaceae family: a preliminary screening","volume":"115","author":"Famuyide","year":"2018","journal-title":"S. Afr. J. Bot."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681830590X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S004520681830590X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T02:15:13Z","timestamp":1661739313000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S004520681830590X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":39,"alternative-id":["S004520681830590X"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.08.012","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}